Patents by Inventor Vincent Cailly-Dufestel

Vincent Cailly-Dufestel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150246035
    Abstract: Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: April 29, 2015
    Publication date: September 3, 2015
    Applicant: ETHYPHARM SA
    Inventors: Vincent CAILLY-DUFESTEL, Catherine HERRY, Johnatan BACON, Pascal OURY
  • Patent number: 8501160
    Abstract: Water-insoluble matrix tablets based on oxycodone or one of its pharmaceutically acceptable salts and capable of prolonged release of oxycodone to the body, exhibiting a crush resistance of at least 4 MPa.
    Type: Grant
    Filed: March 1, 2007
    Date of Patent: August 6, 2013
    Assignee: Ethypharm SA
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury
  • Publication number: 20100015223
    Abstract: Water-insoluble matrix tablets which are capable of prolonged release of active principles liable to be diverted for drug addiction purposes, the said active principles being dispersed within a tabletting matrix composed of at least one excipient selected from the group consisting of pH-independent, water-insoluble delay polymers, inorganic excipients and mixtures thereof, and exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: March 1, 2007
    Publication date: January 21, 2010
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury
  • Publication number: 20090011016
    Abstract: Water-insoluble matrix tablets based on oxycodone or one of its pharmaceutically acceptable salts and capable of prolonged release of oxycodone to the body, exhibiting a crush resistance of at least 4 MPa.
    Type: Application
    Filed: March 1, 2007
    Publication date: January 8, 2009
    Inventors: Vincent Cailly-Dufestel, Catherine Herry, Johnatan Bacon, Pascal Oury